Literature DB >> 30764707

The great escape: How metastases of melanoma, and other carcinomas, avoid elimination.

Alan Wells1,2,3,4,5, Amanda Clark1, Andrew Bradshaw1,3, Bo Ma1,3,5, Howard Edington6.   

Abstract

IMPACT STATEMENT: Cancers kill mainly because metastatic disease is resistant to systemic therapies. It was hoped that newer targeted and immunomodulatory interventions could overcome these issues. However, recent findings point to a generalized resistance to elimination imparted by both cancer-intrinsic and -extrinsic changes to provide survival advantages to the disseminated tumor cells. Here, we present a novel conceptual framework for the microenvironmental inputs and changes that contribute to this generalized therapeutic resistance. In addition we address the issues of experimental systems in terms of studying this phenomenon with their advantages and limitations. This is meant to spur studies into this critical aspect of tumor progression that directly leads to cancer mortality.

Entities:  

Keywords:  Liver metastasis; hepatic niche; metastatic models; microphysiological; tumor microenvironment

Mesh:

Year:  2019        PMID: 30764707      PMCID: PMC6348591          DOI: 10.1177/1535370218820287

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  88 in total

Review 1.  Skin tissue repair: Matrix microenvironmental influences.

Authors:  Alan Wells; Austin Nuschke; Cecelia C Yates
Journal:  Matrix Biol       Date:  2015-08-14       Impact factor: 11.583

2.  Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene.

Authors:  L Bouchard; L Lamarre; P J Tremblay; P Jolicoeur
Journal:  Cell       Date:  1989-06-16       Impact factor: 41.582

3.  Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance.

Authors:  Elizabeth S Nakasone; Hanne A Askautrud; Tim Kees; Jae-Hyun Park; Vicki Plaks; Andrew J Ewald; Miriam Fein; Morten G Rasch; Ying-Xim Tan; Jing Qiu; Juwon Park; Pranay Sinha; Mina J Bissell; Eirik Frengen; Zena Werb; Mikala Egeblad
Journal:  Cancer Cell       Date:  2012-04-17       Impact factor: 31.743

4.  Reactive astrocytes protect melanoma cells from chemotherapy by sequestering intracellular calcium through gap junction communication channels.

Authors:  Qingtang Lin; Krishnakumar Balasubramanian; Dominic Fan; Sun-Jin Kim; Lixia Guo; Hua Wang; Menashe Bar-Eli; Kenneth D Aldape; Isaiah J Fidler
Journal:  Neoplasia       Date:  2010-09       Impact factor: 5.715

5.  Breast cancer-derived extracellular vesicles stimulate myofibroblast differentiation and pro-angiogenic behavior of adipose stem cells.

Authors:  Young Hye Song; Christine Warncke; Sung Jin Choi; Siyoung Choi; Aaron E Chiou; Lu Ling; Han-Yuan Liu; Susan Daniel; Marc A Antonyak; Richard A Cerione; Claudia Fischbach
Journal:  Matrix Biol       Date:  2016-11-29       Impact factor: 11.583

6.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Authors:  Massimo Cristofanilli; G Thomas Budd; Matthew J Ellis; Alison Stopeck; Jeri Matera; M Craig Miller; James M Reuben; Gerald V Doyle; W Jeffrey Allard; Leon W M M Terstappen; Daniel F Hayes
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

Review 7.  Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion.

Authors:  Jelena Grahovac; Alan Wells
Journal:  Lab Invest       Date:  2013-11-18       Impact factor: 5.662

8.  Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline.

Authors:  C Yates; A Wells; T Turner
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

9.  Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin.

Authors:  C C Yates; C R Shepard; D B Stolz; A Wells
Journal:  Br J Cancer       Date:  2007-04-03       Impact factor: 7.640

10.  Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers.

Authors:  Roni Allaoui; Caroline Bergenfelz; Sofie Mohlin; Catharina Hagerling; Kiarash Salari; Zena Werb; Robin L Anderson; Stephen P Ethier; Karin Jirström; Sven Påhlman; Daniel Bexell; Balázs Tahin; Martin E Johansson; Christer Larsson; Karin Leandersson
Journal:  Nat Commun       Date:  2016-10-11       Impact factor: 14.919

View more
  5 in total

Review 1.  The pan-therapeutic resistance of disseminated tumor cells: Role of phenotypic plasticity and the metastatic microenvironment.

Authors:  Bo Ma; Alan Wells; Amanda M Clark
Journal:  Semin Cancer Biol       Date:  2019-07-31       Impact factor: 15.707

Review 2.  Human biomimetic liver microphysiology systems in drug development and precision medicine.

Authors:  Albert Gough; Alejandro Soto-Gutierrez; Lawrence Vernetti; Mo R Ebrahimkhani; Andrew M Stern; D Lansing Taylor
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-12-17       Impact factor: 73.082

Review 3.  Mini-Review: Can the Metastatic Cascade Be Inhibited by Targeting CD147/EMMPRIN to Prevent Tumor Recurrence?

Authors:  Michal A Rahat
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

4.  Expression of E-cadherin and specific CXCR3 isoforms impact each other in prostate cancer.

Authors:  Bo Ma; Ahmad Khazali; Hanshuang Shao; Yuhan Jiang; Alan Wells
Journal:  Cell Commun Signal       Date:  2019-12-12       Impact factor: 5.712

Review 5.  A Perspective on Therapeutic Pan-Resistance in Metastatic Cancer.

Authors:  Dimitrios Korentzelos; Amanda M Clark; Alan Wells
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.